相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
Paul Bird et al.
CLINICAL RHEUMATOLOGY (2022)
Long-term remission and biologic persistence rates: 12-year real-world data
Kieran Murray et al.
ARTHRITIS RESEARCH & THERAPY (2021)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry
Christos G. Papadopoulos et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2019)
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients
Laure Gossec et al.
CLINICAL RHEUMATOLOGY (2018)
Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
Masato Ishida et al.
MODERN RHEUMATOLOGY (2018)
Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial
Agnes Zak et al.
RHEUMATOLOGY (2018)
Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
Klaus Krueger et al.
BMJ OPEN (2018)
Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study
Markus Gaubitz et al.
CLINICAL RHEUMATOLOGY (2017)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany
Christof Iking-Konert et al.
RHEUMATOLOGY (2016)
Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Katie L. Druce et al.
RHEUMATOLOGY (2016)
Treat to Target in Rheumatoid Arthritis
Daniel H. Solomon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study
Paul Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion
Marloes Vermeer et al.
RHEUMATOLOGY (2012)
German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm
K. Krueger et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2012)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Treatment of rheumatoid arthritis: state of the art 2009
Ronald F. van Vollenhoven
NATURE REVIEWS RHEUMATOLOGY (2009)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study - Comparison of patients according to their eligibility for major randomized clinical trials
Angela Zink et al.
ARTHRITIS AND RHEUMATISM (2006)
Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low - results from RABBIT, the German biologics register
Joachim Listing et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Etanercept versus methotrexate in patients with early rheumatoid arthritis - Two-year radiographic and clinical outcomes
MC Genovese et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
